Hemophilia Market Key Drivers, Analysis, Trends, Overview And Forecast To 2033

"The new report published by The Business Research Company, titled Hemophilia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the hemophilia market size has grown strongly in recent years. It will grow from $12.59 billion in 2023 to $13.83 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The hemophilia market size is expected to see strong growth in the next few years. It will grow to $19.4 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12905&type=smp

Rising Occurrence Of Genetic Abnormalities Fuels Hemophilia Market Growth
The rising occurrence of genetic abnormalities is expected to propel the growth of the hemophilia market going forward. Genetic abnormalities, also known as genetic mutations or genetic disorders, refer to changes in the DNA sequence of an individual's genes that can result in various health conditions and physical traits. Hemophilia treatment aims to prevent or control bleeding episodes, minimize complications and improve the quality of life for individuals with genetic abnormalities. For instance, in June 2023, according to Gene People, a UK-based registered charity organization that supports genetic conditions, one in every 25 kids had a genetic disorder. Consequently, 30,000 new-borns and young children in the UK and more than 2.4 million children and adults are affected by a genetic disorder each year. Therefore, the rising occurrence of genetic abnormalities is driving the growth of the hemophilia market.

Major Players In The Hemophilia Market Lead With Innovative Drugs Such As Altuviiio
Major companies operating in the hemophilia market are developing innovative drugs such as ALTUVIIIO to sustain their position in the market. For instance, in February 2023, Sanofi S.A., a France-based pharmaceutical and healthcare company, launched ALTUVIIIO for hemophilia, which was approved by The Food and Drug Administration (FDA), a US-based government agency. With once-weekly dosing, ALTUVIIIO is the first and only hemophilia A medication to offer regular to near-normal factor activity levels (above 40%) for most of the week and dramatically lessen bleeding compared to previous factor VIII prophylaxis.

The hemophilia market covered in this report is segmented -

1) By Type: Hemophilia A; Hemophilia B; Hemophilia C; Other Types
2) By Treatment: Replacement Therapy; Hemostatic Agents; Desmopressin; Gene Therapy; Other Treatments
3) By End-User: Hospitals; Clinics; Home Care Settings; Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12905&type=discount

Major players in the hemophilia market are Kedrion S.p.A., Chugai Pharmaceutical Co. Ltd., Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Baxter International Inc., CSL Limited, Biogen Inc., Grifols S.A., Octapharma AG, BioMarin Pharmaceutical Inc., GC Pharma, Alnylam Pharmaceuticals Inc., Bio Products Laboratory Ltd., Sangamo Therapeutics Inc., UniQure, Intellia tx, ProMetic BioSciences Ltd., Precision BioLogic Inc., Dimension Therapeutics, Chameleon Biosciences, Amarna therapeutics, HEMA Biologics LLC, Aptevo Therapeutics, Arcturus Therapeutics Inc., Ferring Lakemedel AB.

Contents of the report:
1. Executive Summary
2. Hemophilia Market Report Structure
3. Hemophilia Market Trends And Strategies
4. Hemophilia Market - Macro Economic Scenario
5. Hemophilia Market Size And Growth
…..
27. Hemophilia Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/hemophilia-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.